- Home
- PINE vs CATX Comparison
PINE vs CATX Comparison
Compare PINE & CATX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PINE
- CATX
- Stock Information
- Founded
- PINE 2019
- CATX 1983
- Country
- PINE United States
- CATX United States
- Employees
- PINE N/A
- CATX N/A
- Industry
- PINE Real Estate Investment Trusts
- CATX Medical/Dental Instruments
- Sector
- PINE Real Estate
- CATX Health Care
- Exchange
- PINE Nasdaq
- CATX Nasdaq
- Market Cap
- PINE 219.7M
- CATX 182.9M
- IPO Year
- PINE 2019
- CATX N/A
- Fundamental
- Price
- PINE $15.20
- CATX $2.34
- Analyst Decision
- PINE Strong Buy
- CATX Strong Buy
- Analyst Count
- PINE 8
- CATX 10
- Target Price
- PINE $19.38
- CATX $13.89
- AVG Volume (30 Days)
- PINE 73.1K
- CATX 633.3K
- Earning Date
- PINE 04-24-2025
- CATX 05-12-2025
- Dividend Yield
- PINE 7.38%
- CATX N/A
- EPS Growth
- PINE N/A
- CATX N/A
- EPS
- PINE 0.07
- CATX N/A
- Revenue
- PINE $53,967,000.00
- CATX $1,454,000.00
- Revenue This Year
- PINE $7.94
- CATX N/A
- Revenue Next Year
- PINE $2.82
- CATX N/A
- P/E Ratio
- PINE $204.16
- CATX N/A
- Revenue Growth
- PINE 14.94
- CATX 1.40
- 52 Week Low
- PINE $14.51
- CATX $1.60
- 52 Week High
- PINE $19.42
- CATX $19.10
- Technical
- Relative Strength Index (RSI)
- PINE 38.69
- CATX 51.17
- Support Level
- PINE $14.94
- CATX $2.18
- Resistance Level
- PINE $15.41
- CATX $2.65
- Average True Range (ATR)
- PINE 0.35
- CATX 0.16
- MACD
- PINE -0.06
- CATX 0.02
- Stochastic Oscillator
- PINE 16.15
- CATX 56.25
About PINE Alpine Income Property Trust Inc.
Alpine Income Property Trust Inc is a real estate investment trust (REIT) that owns and operates a high-quality portfolio of commercial net lease properties in the United States. The company's portfolio predominantly comprises single-tenant retail properties located in or near metropolitan statistical areas, or MSAs. It operates in two business segments: income properties, which derive maximum revenue, and commercial loans and investments.
About CATX Perspective Therapeutics Inc.
Perspective Therapeutics Inc is a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha-emitting isotope Lead-212 (212Pb) to deliver powerful radiation specifically to cancer cells via specialized targeting moieties.